GSA CAPITAL PARTNERS LLP - BELLEROPHON THERAPEUTICS INC ownership

BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771300. A total of 41 filers reported holding BELLEROPHON THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 1.7%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of BELLEROPHON THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$330,000
-16.9%
63,566
+6.7%
0.06%
-15.4%
Q4 2020$397,000
+38.8%
59,589
+112.1%
0.06%
+35.4%
Q3 2020$286,00028,0920.05%
Other shareholders
BELLEROPHON THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 61,042$317,0000.36%
GSA CAPITAL PARTNERS LLP 63,566$330,0000.06%
NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. 252,650$1,311,0000.03%
ELEMENT CAPITAL MANAGEMENT LLC 11,646$60,0000.01%
CAAS CAPITAL MANAGEMENT LP 97,900$508,0000.01%
DAVENPORT & Co LLC 98,975$514,0000.01%
TUDOR INVESTMENT CORP ET AL 20,000$104,0000.00%
Renaissance Technologies 233,799$1,213,0000.00%
Professional Financial Advisors, LLC 500$3,0000.00%
Laurion Capital Management LP 20,000$104,0000.00%
View complete list of BELLEROPHON THERAPEUTICS INC shareholders